Lee Scott Newman
Physician at 6 Ave, Denver, CO
License number
Colorado 25804
Issued Date
Jan 12, 1984
Renew Date
May 1, 2015
Expiration Date
Apr 30, 2017
Type
Physician
Address
Address
5900 E 6Th Ave, Denver, CO 80220
Professional information
Director At Mountain And Plains Education And Research Center
Position:
Chief Medical Information Officer at Axion Health, Inc., Professor at University of Colorado at Denver and Health Sciences Center, Director at Mountain and Plains Education and Research Center
Location:
Greater Denver Area
Industry:
Information Technology and Services
Work:
Axion Health, Inc.
since Aug 2012
-
Chief Medical Information Officer
University of Colorado at Denver and Health Sciences Center
since Jul 1987
-
Professor
Mountain and Plains Education and Research Center
- Colorado School of Public Health, Aurora, CO since 2007
-
Director
Axion Health Inc.
Jul 2004 - Aug 2012
-
CEO
National Jewish Medical and Research Center
Jul 1987 - Dec 2004
-
Professor and Staff Physician
Education:
University of Colorado School of Medicine 1984 - 1987
Fellowship, Pulmonary and Critical Care Medicine Emory University School of Medicine 1980 - 1983
Internship and Residency, Internal Medicine Vanderbilt University School of Medicine 1976 - 1980
MD, Medicine Cornell University 1975 - 1977
MA, Social Psychology Amherst College 1971 - 1975
BA, Psychology
Fellowship, Pulmonary and Critical Care Medicine Emory University School of Medicine 1980 - 1983
Internship and Residency, Internal Medicine Vanderbilt University School of Medicine 1976 - 1980
MD, Medicine Cornell University 1975 - 1977
MA, Social Psychology Amherst College 1971 - 1975
BA, Psychology
Honor & Awards:
Fellow, American College of Occupational and Environmental Medicine, 2004-
Fellow, American College of Chest Physicians, 1990-
Fellow, Collegium Ramazzini, 2004-
Castle Connolly Top Doctor Award, 2001-2010
Best Doctors in America, 2002-2010
Lee S Newman, Aurora CO
Specialties:
Pulmonologist
Address:
13001 E. 17Th Place, Aurora, CO 80045
Education:
Vanderbilt University, School of Medicine - Doctor of Medicine
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Pulmonary Disease (Internal Medicine)
University of Colorado Hospital-Anschutz Inpatient Pavilion - Fellowship - Pulmonary Disease (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Methods And Compositions For 10Beryllium Complex Probes
US Patent:
2007001, Jan 18, 2007
Filed:
Jul 14, 2006
Appl. No.:
11/486682
Inventors:
Richard Sawyer - Rockville MD, US
Brian Day - Englewood CO, US
Lee Newman - Denver CO, US
Brian Day - Englewood CO, US
Lee Newman - Denver CO, US
International Classification:
A61K 51/00
US Classification:
424001110
Abstract:
The present invention concerns methods and compositions for making and using Be complexes of defined compositions, which may have multiple functionalities and/or binding specificities. In various embodiment, Beryllium (Be) complexes may include Be such as Be and Be complexes. Such complexes find use in a wide variety of applications, particularly in the field of treatment, detection and/or diagnosis of infections, diseases and other health-related conditions, including but not limited to cancer, autoimmune disease, cardiovascular disease, metabolic diseases, degenerative diseases, and organ transplant rejection. In addition, a Be complex may be used in a BeLPT assay
Methods And Compositions For Beryllium-Induced Disease
US Patent:
2006026, Nov 23, 2006
Filed:
Mar 10, 2006
Appl. No.:
11/373581
Inventors:
Andrew Fontenot - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
Brian Kotzin - Westlake CA, US
Lee Newman - Denver CO, US
Lisa Maier - Denver CO, US
International Classification:
C12Q 1/00, G01N 33/567, G01N 33/20
US Classification:
435004000, 435007200, 436080000
Abstract:
The present invention provides for methods for detection, diagnosis and prognosis of beryllium-induced disease. In one embodiment, the methods include exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing the Th-1 cytokines produced. Other embodiments include the use of exposing immune cells from subjects suspected of having beryllium-induced disease to beryllium and assessing Th-1 cytokines produced and using these assessments to indicate the stage of progression of the disease. Therapeutic methods involve assessing the onset or progression of beryllium-induced disease before during and after exposure to a treatment for the disease.
Methods For Treatment Of Thiol-Containing Compound Deficient Conditions
US Patent:
7498047, Mar 3, 2009
Filed:
Aug 24, 2005
Appl. No.:
11/211369
Inventors:
Brian J. Day - Englewood CO, US
Richard T. Sawyer - Rockville MD, US
Lee S. Newman - Denver CO, US
Richard T. Sawyer - Rockville MD, US
Lee S. Newman - Denver CO, US
Assignee:
National Jewish Medical and Research Center - Denver CO
International Classification:
A61K 35/42
US Classification:
424557, 435 77
Abstract:
Methods for therapy of cystic fibrosis and other conditions are provided. The methods comprise one or more agents capable of increasing thiol-containing compound transport via a transporter system (i. e. ABC transporters such as MDR-1 or MRP-2) in cells. Other embodiments include the use of agents to modulate transport of thiol-containing compounds within the cell. Therapeutic methods involve the administration of such agents to a patient afflicted with cystic fibrosis and/or another condition responsive to stimulation of thiol-containing compound transport.